Pozen 4Q net loss $2.2 million
CHAPEL HILL – The Chapel Hill-based drug development company Pozen reported Wednesday that its net loss narrowed in the fourth quarter to $2.2 million, down from $6.1 million in the prior year.
The company reported total revenues of $4.7 million for the quarter in a news release Wednesday. In addition to receiving $1.7 million in royalties from sales of the osteoarthritis a pain treatment Vimovo, the company also received $3 million in revenues as part of a fee for the licensing of its new aspirin candidates to Sanofi U.S.
The company signed an agreement with Sanofi for the commercialization of its aspirin drug candidates in the United States. The candidates, which were developed for use for the secondary-prevention of cardiovascular disease in patients at-risk for aspirin-induced gastric ulcers, are pending approval by the U.S. Food and Drug Administration.
Biogen Idec hosts students in community lab
MORRISVILLE – Biogen Idec was expected to open the doors to its new “RTP Community Lab” for more than 100 Wake County middle school students on Wednesday.
The company hosted the students as part of the Students@Work initiative that aims to help middle school students connect what they’re learning in class with future career opportunities, according to a news release from the company.
Biogen Idec’s “RTP Community Lab” is a laboratory classroom. This was the first program to be held at the location. The lab will officially open to the public in the fall for access by students in Wake and Durham counties.
Verizon hiring 89 in N.C.
RALEIGH – Verizon Wireless announced this week that it will be adding 89 full-time customer specialists and retail employees based in North Carolina before April Candidates can apply online by through Verizon Wireless website www.vzwcareers.com.
Verizon employs 2,600 people in the state, according to a news release.